IMPURITIES AVAILABLE FOR 'Ruxolitinib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Ruxolitinib. Ruxolitinib is an oral medication used to treat certain bone marrow disorders, including myelofibrosis, polycythemia vera, and graft-versus-host disease (GVHD). It works by inhibiting Janus kinase (JAK) 1 and 2, enzymes involved in the signaling pathways that regulate blood cell production and immune function. By blocking these pathways, ruxolitinib reduces abnormal cell growth and inflammation. It helps improve symptoms such as enlarged spleen, fatigue, and night sweats in myeloproliferative diseases. Common side effects include anemia, low platelet counts, dizziness, and increased risk of infections. Regular blood monitoring is necessary during treatment to manage potential hematologic side effects. Buy high quality Ruxolitinib from Omsynth Lifesciences.